Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis

Journal of Experimental Medicine

Volumn 205, Issue 6, 2008, Pages 1277-1283

  Plitas, George ^a   Burt, Bryan M ^a   Nguyen, Hoang M ^a   Bamboat, Zubin M ^a   DeMatteo, Ronald P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; TOLL LIKE RECEPTOR 9;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GRANULOCYTE; INFLAMMATION; INHIBITION KINETICS; INNATE IMMUNITY; MORTALITY; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; SEPSIS; SURVIVAL; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; BACTERIAL INFECTIONS; CYTOKINES; DENDRITIC CELLS; GRANULOCYTES; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEPSIS; SURVIVORS; TOLL-LIKE RECEPTOR 9;

EID: 45149129895     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20080162     Document Type: Article

References (28)

1. Riedemann, N.C., R.F. Guo, and P.A. Ward. 2003. The enigma of sepsis. J. Clin. Invest. 112:460-467.
2. Hotchkiss, R.S., and I.E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138-150.
3. Riedemann, N.C., R.F. Guo, and P.A. Ward. 2003. Novel strategies for the treatment of sepsis. Nat. Med. 9:517-524.
4. Russell, J.A. 2006. Management of sepsis. N. Engl. J. Med. 355:1699-1713.
5. Sprung, C.L., D. Annane, D. Keh, R. Moreno, M. Singer, K. Freivogel, Y.G. Weiss, J. Benbenishty, A. Kalenka, H. Forst, et al. 2008. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med. 358:111-124.
6. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135-145.
7. Weighardt, H., S. Kaiser-Moore, R.M. Vabulas, C.J. Kirschning, H. Wagner, and B. Holzmann. 2002. Cutting edge: myeloid diff erentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J. Immunol. 169:2823-2827.
8. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:115-122.
9. Qin, S., H. Wang, R. Yuan, H. Li, M. Ochani, K. Ochani, M. Rosas-Ballina, C.J. Czura, J.M. Huston, E. Miller, et al. 2006. Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med. 203:1637-1642.
10. Hotchkiss, R.S., K.C. Chang, P.E. Swanson, K.W. Tinsley, J.J. Hui, P. Klender, S. Xanthoudakis, S. Roy, C. Black, E. Grimm, et al. 2000. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1:496-501.
11. Ishii, K.J., and S. Akira. 2006. Innate immune recognition of, and regulation by, DNA. Trends Immunol. 27:525-532.
12. Sester, D.P., K.J. Stacey, M.J. Sweet, S.J. Beasley, S.L. Cronau, and D.A. Hume. 1999. The actions of bacterial DNA on murine macrophages. J. Leukoc. Biol. 66:542-548.
13. Del Prete, A., W. Vermi, E. Dander, K. Otero, L. Barberis, W. Luini, S. Bernasconi, M. Sironi, A. Santoro, C. Garlanda, et al. 2004. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. EMBO J. 23:3505-3515.
14. Gunn, M.D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L.T. Williams, and H. Nakano. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451-460.
15. Tinsley, K.W., M.H. Grayson, P.E. Swanson, A.M. Drewry, K.C. Chang, I.E. Karl, and R.S. Hotchkiss. 2003. Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells. J. Immunol. 171:909-914.
16. Scumpia, P.O., P.F. McAuliff e, K.A. O'Malley, R. Ungaro, T. Uchida, T. Matsumoto, D.G. Remick, M.J. Clare-Salzler, L.L. Moldawer, and P.A. Efron. 2005. CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis. J. Immunol. 175:3282-3286.
17. Benjamim, C.F., S.K. Lundy, N.W. Lukacs, C.M. Hogaboam, and S.L. Kunkel. 2005. Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood. 105:3588-3595.
18. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6:173-182.
19. Guo, Z., M. Zhang, H. Tang, and X. Cao. 2005. Fas signal links innate and adaptive immunity by promoting dendritic-cell secretion of CC and CXC chemokines. Blood. 106:2033-2041.
20. Krieg, A.M., T. Wu, R. Weeratna, S.M. Efler, L. Love-Homan, L. Yang, A.K. Yi, D. Short, and H.L. Davis. 1998. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA. 95:12631-12636.
21. Bhan, U., N.W. Lukacs, J.J. Osterholzer, M.W. Newstead, X. Zeng, T.A. Moore, T.R. McMillan, A.M. Krieg, S. Akira, and T.J. Standiford. 2007. TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells. J. Immunol. 179:3937-3946.
22. Albiger, B., S. Dahlberg, A. Sandgren, F. Wartha, K. Beiter, H. Katsuragi, S. Akira, S. Normark, and B. Henriques-Normark. 2007. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell. Microbiol. 9:633-644.
23. Minns, L.A., L.C. Menard, D.M. Foureau, S. Darche, C. Ronet, D.W. Mielcarz, D. Buzoni-Gatel, and L.H. Kasper. 2006. TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii. J. Immunol. 176:7589-7597.
24. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature. 408:740-745.
25. Lehmann, V., M.A. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D- galactosamine-treated mice. J. Exp. Med. 165:657-663.
26. Rittirsch, D., L.M. Hoesel, and P.A. Ward. 2007. The disconnect between animal models of sepsis and human sepsis. J. Leukoc. Biol. 81:137-143.
27. Echtenacher, B., W. Falk, D.N. Mannel, and P.H. Krammer. 1990. Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145:3762-3766.
28. Cerullo, V., M.P. Seiler, V. Mane, N. Brunetti-Pierri, C. Clarke, T.K. Bertin, J.R. Rodgers, and B. Lee. 2007. Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol. Ther. 15:378-385.